Prevalence Trend and Predictors of Clostridium Difficile Infection in Sickle Cell Disease Patients

Abstract

Introduction:Patients with Sickle Cell Disease (SCD) have numerous risk factors including but not limited to iron overload, avascular bone necrosis, infection especially acute chest syndrome and frequent pain crisis. Incidence of Clostridium Difficile infection (C. Diff) in sickle cell disease patients is lower than the general population but they are frequently hospitalized for vaso-occlusive crisis and are often given empirical antibiotic treatment which puts them at high risk for C. Diff (1). Here we are describing trends and predictors of C. Diff among SCD patients and how C.diff burgen has changed over the time in Sickle cell patients. Methods:We used National Inpatient Sample (NIS) for the years 2008-2017 by Healthcare Cost and Utilization Project. We extracted a study cohort of all-cause hospitalizations among SCD patients using International Classification of Diseases (9th/10th Editions) Clinical Modification diagnosis codes (ICD-9-CM/ICD-10-CM). Concurrent C. Diff and other comorbidities were identified by ICD-9/10-CM codes and Elixhauser comorbidity software. Our primary objective was to delineate temporal trends, and predictors of C. Diff infection in SCD patients. We utilized Cochran Armitage trend test and multivariable survey logistic regression models to analyze the trends, predictors and outcomes. Results:Out of a total 991,848 all-cause hospitalizations among SCD patients, 5,182 (1.81%) hospitalizations were complicated with C. Diff infection. Prevalence of C.Diff infection increased from 3/1000 hospitalizations in 2008 to 6/1000 hospitalizations in 2017 (pTrend<0.0001) with a 6% yearly increase (OR:1.06; 95%CI:1.04-1.09; p<0.001) (Figure.1). Patients who developed C.Diff infection had higher mean age (39 vs 33-years; p<0.001), and more likely to be females (62% vs 38%; p<0.001). Furthermore, in multivariable regression analysis, increasing age (OR:1.1; 95%CI:1.1-1.1; p<0.0001), females (OR:1.2; 95%CI:1.1-1.4; p<0.001), neurological disorders (OR:1.6; 95%CI:1.2-1.9; p<0.001), weight loss (OR:2.5; 95%CI:2.0-3.2; p<0.001), depression (OR:1.5; 95%CI:1.2-1.9; p<0.001), and renal failure (OR:1.3; 95%CI:1.2-1.6; p<0.001) were associated with higher odds of C. Diff infection. Also other concurrent conditions like liver disorders (OR:1.5; 95%CI:1.2-2.0; p<0.001), congestive heart failure (OR:1.3; 95%CI:1.1-1.6; p<0.001), and septicemia (OR:3.6; 95%CI:3.1-4.3; p<0.001) were also associated with increased odds of developing C.Diff infection. Among the patients who developed C.Diff infection, 15% were discharged to long term facilities and 4% died during the hospitalization. Moreover C.Diff infection was also associated with higher length of stay (11 vs 6-days; p<0.001). Discussion:In this nationally representative study, we observed that prevalence of C.Diff among SCD has been increasing over the last decade. We were also able to delineate several factors such as renal failure, liver disorder, CHF and septicemia which were significantly associated with development of C.Diff infection. Modifiable factors require better optimization which may eventually decrease the C.diff infection prevalence but this conclusion needs more in-depth studies to establish the causal relationship. References: (1) Ahmed J, Kumar A, Jafri F, Batool S, Knoll B, Lim SH. Low Incidence of Hospital-OnsetClostridium difficileInfection in Sickle Cell Disease.N Engl J Med. 2019;380(9):887-888. doi:10.1056/NEJMc1815711 Disclosures No relevant conflicts of interest to declare.

Unveiling the Risk Factors of Clostridioides difficile Infection in Children; A Multicenter Retrospective Case-control Study in the Eastern Region, Saudi Arabia

“…In general, SCD patients receive repeated doses of empirical antibiotics which poses a potential for increasing the rate of CDI, that is ultimately associated with excessive antibiotic treatment 22 . Other authors 23 , had observed the increased CDI prevalence among SCD over the last decade, which is also consistent with our results. Nevertheless, the rate of CDI in both pediatric and adult SCD patients was found to be low because the SCD microbiome has protected the patients from CDI by changing their intestinal metabolome [24][25][26] .…”